The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy.
 
Paul Swiecicki
No Relationships to Disclose
 
Matthew J Schipper
No Relationships to Disclose
 
Kelly M Malloy
No Relationships to Disclose
 
Chaz Stucken
No Relationships to Disclose
 
Andrew G Shuman
No Relationships to Disclose
 
Matthew E Spector
No Relationships to Disclose
 
Douglas Brian Chepeha
No Relationships to Disclose
 
Keith Casper
No Relationships to Disclose
 
Scott A McLean
No Relationships to Disclose
 
Jeffrey Moyer
No Relationships to Disclose
 
Gregory T. Wolf
Consulting or Advisory Role - IRX Therapeutics
Research Funding - IRX Therapeutics (Inst)
Travel, Accommodations, Expenses - IRX Therapeutics
 
Mark E Prince
No Relationships to Disclose
 
Carol Rossier Bradford
No Relationships to Disclose
 
Thomas E. Carey
No Relationships to Disclose
 
Avraham Eisbruch
No Relationships to Disclose
 
Shruti Jolly
No Relationships to Disclose
 
Francis P. Worden
Honoraria - Bayer
Consulting or Advisory Role - Bayer/Onyx
Travel, Accommodations, Expenses - Bayer/Onyx